深吸气屏气技术在左侧乳腺癌放疗中的临床效用
本前瞻性研究评估深吸气屏气(DIBH)在左侧乳腺癌放疗中的剂量学与可行性,130例入组患者中26例不适合该技术,16例DIBH计划未满足心脏或LAD剂量约束;DIBH可显著降低心脏和LAD剂量,但约三分之一患者获益有限或不获益。
要点
- DIBH使左侧乳腺癌放疗心脏平均剂量降低超50%,LAD平均剂量降低超40%。
- 约20%入组患者不适合DIBH或DIBH计划未满足心脏/LAD剂量约束。
- 部分全乳照射患者俯卧或仰卧自由呼吸计划的心脏/LAD剂量参数更优。
核心结论
- DIBH是左侧乳腺癌放疗中优秀的心脏保护技术,但约三分之一患者不获益或获益少于替代方法。
研究设计与样本
- 前瞻性试验纳入130例左侧乳腺癌患者,均行仰卧位DIBH和自由呼吸(FB)计划CT,全乳照射者另加俯卧位CT。
- 采用三维适形放疗(3DCRT)计划分析心脏、左前降支(LAD)、同侧肺和对侧乳腺剂量。
- 分析患者和工作人员对DIBH技术的接受度,并收集放疗后副作用包括放射性肺改变。
主要发现
- 130例入组患者中26例不适合该技术,16例DIBH计划未满足心脏或LAD剂量约束。
- 54例全乳照射和34例乳房切除术后/淋巴结放疗患者采用DIBH,心脏平均剂量降至FB的<50%,心脏V25 Gy降至<20%,LAD平均剂量降至<40%,LAD最大剂量降至约50%。
- DIBH获益幅度与同侧肺体积相对增加相关,但心脏和LAD剂量差异(DIBH vs FB)个体间存在变异。
- 全乳照射病例中,分别有15例和4例在俯卧位或仰卧位FB计划中至少一项心脏/LAD剂量参数更优,差异数值上较小。
- 所有DIBH患者完成放疗,分次间重定位精度和放射副作用与其他乳腺放疗技术相似,患者和放射技师均对技术满意。
关键数值与推荐
- DIBH计划中心脏平均剂量降至FB的<50%,心脏V25 Gy降至<20%。
- DIBH计划中LAD平均剂量降至FB的<40%,LAD最大剂量降至FB的约50%。
临床怎么用
- 左侧乳腺癌放疗可考虑DIBH以降低心脏和LAD剂量,但需评估患者 suitability 和计划剂量约束。
- DIBH获益与同侧肺体积增加相关,个体差异需通过计划比较确认。
- 全乳照射患者可比较俯卧位或仰卧位FB计划,部分病例这些计划的心脏/LAD剂量参数更优。
局限性
- 约三分之一患者不适合DIBH或DIBH计划未满足心脏/LAD剂量约束。
- 心脏和LAD剂量差异个体间变异大,DIBH获益不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studying the clinical utility of deep-inspirational breath-hold (DIBH) in left breast cancer radiotherapy (RT) was aimed at focusing on dosimetry and feasibility aspects. METHODS: In this prospective trial all enrolled patients went through planning CT in supine position under both DIBH and free breathing (FB); in whole breast irradiation (WBI) cases prone CT was also taken. In 3-dimensional conformal radiotherapy (3DCRT) plans heart, left anterior descending coronary artery (LAD), ipsilateral lung and contralateral breast doses were analyzed. The acceptance of DIBH technique as reported by the patients and the staff was analyzed; post-RT side-effects including radiation lung changes (visual scores and lung density measurements) were collected. RESULTS: Among 130 enrolled patients 26 were not suitable for the technique while in 16, heart or LAD dose constraints were not met in the DIBH plans. Among 54 and 34 patients receiving WBI and postmastectomy/nodal RT, respectively with DIBH, mean heart dose (MHD) was reduced to < 50%, the heart V25 Gy to < 20%, the LAD mean dose to < 40% and the LAD maximum dose to about 50% as compared to that under FB; the magnitude of benefit was related to the relative increase of the ipsilateral lung volume at DIBH. Nevertheless, heart and LAD dose differences (DIBH vs. FB) individually varied. Among the WBI cases at least one heart/LAD dose parameter was more favorable in the prone or in the supine FB plan in 15 and 4 cases, respectively; differences were numerically small. All DIBH patients completed the RT, inter-fraction repositioning accuracy and radiation side-effects were similar to that of other breast RT techniques. Both the patients and radiographers were satisfied with the technique. CONCLUSIONS: DIBH is an excellent heart sparing technique in breast RT, but about one-third of the patients do not benefit from that otherwise laborious procedure or benefit less than from an alternative method. TRIAL REGISTRATION: retrospectively registered under ISRCTN14360721 (February 12, 2021).
引用
- Gaál S, Kahán Z, Paczona V, et al. Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility. Radiat Oncol. 2021. PMID: 33985547. doi:10.1186/s13014-021-01816-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。